Pain Management Lasers
What Are Erchonia Pain Management Lasers?
Erchonia pain lasers are FDA-cleared, low-level laser therapy (LLLT) systems engineered to address nociceptive musculoskeletal pain without heat, tissue damage, or invasive procedures.
Unlike high-powered surgical or thermal devices, Erchonia lasers deliver precise wavelengths and dosimetry that interact with cellular processes—supporting circulation, cellular energy involved in pain and recovery.
Key Characteristics:
• No Downtime, No Side Effects, No Tissue Destruction
• Non-thermal, Non-invasive, High Laser Energy Output
• FDA-cleared for Musculoskeletal Pain Indications
• Designed for Reproducible, Consistent Clinical Application
XLR8 – Duel Red
Targeted Red Laser Therapy. Entry-Level Precision.
For nearly two decades, Erchonia’s dual-red technology helped define everyday laser therapy in clinical practice—and 635nm red is the wavelength behind Erchonia’s first FDA clearance. The XLR8 delivers straightforward, non-invasive red laser application for clinics that want a trusted foundation for pain and inflammation-focused protocols.
Best for: Foundational musculoskeletal care and cost-conscious clinical expansion.
EVRL – Violet/Red
Expanded versatility in one handheld system.
The EVRL adds violet to Erchonia’s red platform—broadening clinical capability while staying simple to implement. In Erchonia studies, red + violet demonstrated stronger functional response than red alone, supporting measurable changes like ROM improvement alongside pain reduction. It also opens a second lane for dermatological applications.
Best for: practices that want everyday pain protocols plus added versatility from dual-wavelength capability.
GVL – Green/Violet
Next-generation wavelength science
The GVL introduces Erchonia’s first FDA-cleared green wavelength laser, paired with violet. Green uniquely influences Complex III of the Electron Transport Chain—supporting ATP-related cellular function in a way other wavelengths can’t. In clinical research, green + violet demonstrated meaningful improvements in ROM and pain reduction, including within a single session—making it a powerful platform for both standard care plans and performance-focused outcomes.
Best for: clinicians who want the most advanced wavelength platform integrated into both everyday pain protocols and performance-driven care.
FX Series Scanning Lasers
FDA-Cleared for Low Back Pain.
The FX Series features Erchonia’s automated scanning delivery system—engineered to distribute laser energy across a defined treatment area with controlled rotation and consistency. Unlike fixed-point handheld application, the FX scan pattern allows for efficient coverage of larger anatomical regions.
Most notably, the FX Series holds an FDA clearance for the treatment of low back pain—one of the most common conditions presenting in chiropractic and conservative care practices.
This is a clinically cleared solution for a condition that drives daily patient demand.
Best for: chiropractors and conservative care providers seeking scalable, FDA-cleared low back pain treatment technology.